Definium Therapeutics, Inc. · NASDAQ:DFTX
Krebs Andreas received 4,666 Definium Therapeutics, Inc. shares as an award (Form 4)
Traded Jun 11, 2026 · Filed Jun 15, 2026
On Jun 11, 2026, Krebs Andreas (Director) received 4,666 Definium Therapeutics, Inc. shares as an award, leaving 19,773 shares. Filed Jun 15, 2026 (Form 4).
- Awarded
- 4,666 shares
- Holding after
- 19,773 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Shares | Award | 4,666 | 19,773 | Direct |
Source
Related
- Definium Therapeutics, Inc.
- Krebs Andreas
- Definium Therapeutics, Inc. shareholders
- Form 4 · Krebs Andreas · Sep 18, 2026
- Form 4 · Karlin Daniel · Sep 29, 2026
- Form 4 · Barrow Robert · Sep 29, 2026
- Form 4 · Wiley Matthew T. · Sep 29, 2026
- Form 4 · Sullivan Mark · Sep 29, 2026
- Form 4 · Roberts Brandi · Sep 29, 2026